ERK/p38 MAP-kinases and PI3K are involved in the differential regulation of B7-H1 expression in DC subsets

European Journal of Immunology

Volumn 40, Issue 1, 2010, Pages 254-266

  Karakhanova, Svetlana ^a   Meisel, Stefan ^a   Ring, Sabine ^a   Mahnke, Karsten ^a   Enk, Alexander H ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

B7 H1 regulatory molecules; Dendritic cells; Signal transduction

Indexed keywords

B7 ANTIGEN; CYTOKINE; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3 KINASE; PROGRAMMED DEATH 1 LIGAND 1; TOLL LIKE RECEPTOR; CD274 PROTEIN, HUMAN; LEUKOCYTE ANTIGEN; MITOGEN ACTIVATED PROTEIN KINASE;

ARTICLE; CELL ISOLATION; CELL MATURATION; CELL POPULATION; DENDRITIC CELL; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; UPREGULATION; CELL CULTURE; CELL DIFFERENTIATION; CYTOLOGY; ENZYMOLOGY; IMMUNOLOGY; METABOLISM; SECRETION; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANTIGENS, CD; CELL DIFFERENTIATION; CELLS, CULTURED; CYTOKINES; DENDRITIC CELLS; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; MAP KINASE SIGNALING SYSTEM; P38 MITOGEN-ACTIVATED PROTEIN KINASES; UP-REGULATION;

EID: 74249084110     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.200939289     Document Type: Article

References (61)

1. Steinman, R. M., Hawiger, D. and Nussenzweig, M. C., Tolerogenic dendritic cells*. Annu. Rev. Immunol. 2003. 21: 685-711.
2. Mahnke, K., Knop, J. and Enk, A. H., Induction of tolerogenic DCs: 'you are what you eat'. Trends Immunol. 2003. 24: 646-651.
3. Lanzavecchia, A. and Sallusto, F., Regulation of T cell immunity by dendritic cells. Cell 2001. 106: 263-266.
4. Jonuleit, H., Schmitt, E., Schuler, G., Knop, J. and Enk, A. H., Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J. Exp. Med. 2000. 192: 1213-1222.
5. Mahnke, K., Qian, Y., Knop, J. and Enk, A. H., Induction of CD4+/CD25+ regulatory T cells by targeting of antigens to immature dendritic cells. Blood 2003. 101: 4862-4869.
6. Beswick, E. J., Pinchuk, I. V., Das, S., Powell, D. W. and Reyes, V. E., Expression of the programmed death ligand 1, B7-H1, on gastric epithelial cells after Helicobacter pylori exposure promotes development of CD4+ CD25+ FoxP3+ regulatory T cells. Infect. Immun. 2007. 75: 4334-4341.
7. Chen, L., Zhang, Z., Chen, W., Li, Y., Shi, M., Zhang, J., Wang, S. and Wang, F. S., B7-H1 up-regulation on myeloid dendritic cells significantly suppresses T cell immune function in patients with chronic hepatitis B. J. Immunol. 2007. 178: 6634-6641.
8. Chen, Y., Zhang, J., Li, J., Zou, L., Zhao, T., Tang, Y. and Wu, Y., Expression of B7-H1 in inflammatory renal tubular epithelial cells. Nephron. Exp. Nephrol. 2006. 102: e81-e92.
9. Dong, H., Strome, S. E., Matteson, E. L., Moder, K. G., Flies, D. B., Zhu, G., Tamura, H. et al., Costimulating aberrant T cell responses by B7-H1 autoantibodies in rheumatoid arthritis. J. Clin. Invest. 2003. 111: 363-370.
10. Geng, L., Huang, D., Liu, J., Qian, Y., Deng, J., Li, D., Hu, Z., Zhang, J. et al., B7-H1 up-regulated expression in human pancreatic carcinoma tissue associates with tumor progression. J. Cancer Res. Clin. Oncol. 2008. 134: 1021-1027.
11. Ghebeh, H., Mohammed, S., Al-Omair, A., Qattan, A., Lehe, C., Al-Qudaihi, G., Elkum, N. et al., The B7-H1 (PD-L1) T lymphocyte-inhibitory molecule is expressed in breast cancer patients with infiltrating ductal carcinoma: correlation with important high-risk prognostic factors. Neoplasia 2006. 8: 190-198.
12. Magnus, T., Schreiner, B., Korn, T., Jack, C., Guo, H., Antel, J., Ifergan, I. et al., Microglial expression of the B7 family member B7 homolog 1 confers strong immune inhibition: implications for immune responses and autoimmunity in the CNS. J. Neurosci. 2005. 25: 2537-2546.
13. Greenwald, R. J., Freeman, G. J. and Sharpe, A. H., The B7 family revisited. Annu. Rev. Immunol. 2005. 23: 515-548.
14. Dong, H. and Chen, L., B7-H1 pathway and its role in the evasion of tumor immunity. J. Mol. Med. 2003. 81: 281-287.
15. Blank, C., Brown, I., Peterson, A. C., Spiotto, M., Iwai, Y., Honjo, T. and Gajewski, T. F., PD-L1/B7H-1 inhibits the effector phase of tumor rejection by T cell receptor (TCR) transgenic CD8+ T cells. Cancer Res. 2004. 64: 1140-1145.
16. Hirano, F., Kaneko, K., Tamura, H., Dong, H., Wang, S., Ichikawa, M., Rietz, C. et al., Blockade of B7-H1 and PD-1 by monoclonal antibodies potentiates cancer therapeutic immunity. Cancer Res. 2005. 65: 1089-1096.
17. Saudemont, A. and Quesnel, B., In a model of tumor dormancy, longterm persistent leukemic cells have increased B7-H1 and B7.1 expression and resist CTL-mediated lysis. Blood 2004. 104: 2124-2133.
18. Subudhi, S. K., Alegre, M. L. and Fu, Y. X., The balance of immune responses: costimulation verse coinhibition. J. Mol. Med. 2005. 83: 193-202.
19. Jonuleit, H., Kuhn, U., Muller, G., Steinbrink, K., Paragnik, L., Schmitt, E., Knop, J. and Enk, A. H., Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur. J. Immunol. 1997. 27: 3135-3142.
20. Kadowaki, N., Ho, S., Antonenko, S., Malefyt, R. W., Kastelein, R. A., Bazan, F. and Liu, Y. J., Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J. Exp. Med. 2001. 194: 863-869.
21. Shortman, K. and Liu, Y. J., Mouse and human dendritic cell subtypes. Nat. Rev. Immunol. 2002. 2: 151-161.
22. Carter, L. L., Leach, M. W., Azoitei, M. L., Cui, J., Pelker, J. W., Jussif, J., Benoit, S. et al., PD-1/PD-L1, but not PD-1/PD-L2, interactions regulate the severity of experimental autoimmune encephalomyelitis. J. Neuroimmunol. 2007. 182: 124-134.
23. Cheng, X., Zhao, Z., Ventura, E., Gran, B., Shindler, K. S. and Rostami, A., The PD-1/PD-L pathway is up-regulated during IL-12-induced suppression of EAE mediated by IFN-gamma. J. Neuroimmunol. 2007. 185: 75-86.
24. Ding, H., Wu, X., Wu, J., Yagita, H., He, Y., Zhang, J., Ren, J. and Gao, W., Delivering PD-1 inhibitory signal concomitant with blocking ICOS co-stimulation suppresses lupus-like syndrome in autoimmune BXSB mice. Clin. Immunol. 2006. 118: 258-267.
25. Schreiner, B., Bailey, S. L., Shin, T., Chen, L. and Miller, S. D., PD-1 ligands expressed on myeloid-derived APC in the CNS regulate T-cell responses in EAE. Eur. J. Immunol. 2008. 38: 2706-2717.
26. Zhu, B., Guleria, I., Khosroshahi, A., Chitnis, T., Imitola, J., Azuma, M., Yagita, H. et al., Differential role of programmed death-ligand 1 [corrected] and programmed death-ligand 2 [corrected] in regulating the susceptibility and chronic progression of experimental autoimmune encephalomyelitis. J. Immunol. 2006. 176: 3480-3489.
27. Oikawa, T., Takahashi, H., Ishikawa, T., Hokari, A., Otsuki, N., Azuma, M., Zeniya, M. and Tajiri, H., Intrahepatic expression of the co-stimulatory molecules programmed death-1, and its ligands in autoimmune liver disease. Pathol. Int. 2007. 57: 485-492.
28. Ortler, S., Leder, C., Mittelbronn, M., Zozulya, A. L., Knolle, P. A., Chen, L., Kroner, A. and Wiendl, H., B7-H1 restricts neuroantigen-specific T cell responses and confines inflammatory CNS damage: implications for the lesion pathogenesis of multiple sclerosis. Eur. J. Immunol. 2008. 38: 1734-1744.
29. Schreiner, B., Mitsdoerffer, M., Kieseier, B. C., Chen, L., Hartung, H. P., Weller, M. and Wiendl, H., Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis. J. Neuroimmunol. 2004. 155: 172-182.
30. Wiendl, H., Mitsdoerffer, M., Schneider, D., Chen, L., Lochmuller, H., Melms, A. and Weller, M., Human muscle cells express a B7-related molecule, B7-H1, with strong negative immune regulatory potential: a novel mechanism of counterbalancing the immune attack in idiopathic inflammatory myopathies. FASEB J. 2003. 17: 1892-1894.
31. Dong, H. and Chen, X., Immunoregulatory role of B7-H1 in chronicity of inflammatory responses. Cell Mol. Immunol. 2006. 3: 179-187.
32. Saudemont, A., Jouy, N., Hetuin, D. and Quesnel, B., NK cells that are activated by CXCL10 can kill dormant tumor cells that resist CTL-mediated lysis and can express B7-H1 that stimulates T cells. Blood 2005. 105: 2428-2435.
33. Yamazaki, T., Akiba, H., Koyanagi, A., Azuma, M., Yagita, H. and Okumura, K., Blockade of B7-H1 on macrophages suppresses CD4+ T cell proliferation by augmenting IFN-gamma-induced nitric oxide production. J. Immunol. 2005. 175: 1586-1592.
34. Kanai, T., Totsuka, T., Uraushihara, K., Makita, S., Nakamura, T., Koganei, K., Fukushima, T. et al., Blockade of B7-H1 suppresses the development of chronic intestinal inflammation. J. Immunol. 2003. 171: 4156-4163.
35. Hamanishi, J., Mandai, M., Iwasaki, M., Okazaki, T., Tanaka, Y., Yamaguchi, K., Higuchi, T. et al., Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer. Proc. Natl. Acad. Sci. USA 2007. 104: 3360-3365.
36. Thompson, R. H., Kuntz, S. M., Leibovich, B. C., Dong, H., Lohse, C. M., Webster, W. S., Sengupta, S. et al., Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow-up. Cancer Res. 2006. 66: 3381-3385.
37. Trabattoni, D., Saresella, M., Biasin, M., Boasso, A., Piacentini, L., Ferrante, P., Dong, H. et al., B7-H1 is up-regulated in HIV infection and is a novel surrogate marker of disease progression. Blood 2003. 101: 2514-2520.
38. Curiel, T. J., Wei, S., Dong, H., Alvarez, X., Cheng, P., Mottram, P., Krzysiek, R. et al., Blockade of B7-H1 improves myeloid dendritic cellmediated antitumor immunity. Nat. Med. 2003. 9: 562-567.
39. Perrot, I., Blanchard, D., Freymond, N., Isaac, S., Guibert, B., Pacheco, Y. and Lebecque, S., Dendritic cells infiltrating human non-small cell lung cancer are blocked at immature stage. J. Immunol. 2007. 178: 2763-2769.
40. Velilla, P. A., Montoya, C. J., Hoyos, A., Moreno, M. E., Chougnet, C. and Rugeles, M. T., Effect of intrauterine HIV-1 exposure on the frequency and function of uninfected newborns' dendritic cells. Clin. Immunol. 2008. 126: 243-250.
41. Iwasaki, A. and Medzhitov, R., Toll-like receptor control of the adaptive immune responses. Nat. Immunol. 2004. 5: 987-995.
42. Dempsey, P. W., Doyle, S. E., He, J. Q. and Cheng, G., The signaling adaptors and pathways activated by TNF superfamily. Cytokine Growth Factor Rev. 2003. 14: 193-209.
43. Heinrich, P. C., Behrmann, I., Haan, S., Hermanns, H. M., Muller-Newen, G. and Schaper, F., Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem. J. 2003. 374: 1-20.
44. Castellone, M. D., Teramoto, H., Williams, B. O., Druey, K. M. and Gutkind, J. S., Prostaglandin E2 promotes colon cancer cell growth through a Gs-axin-beta-catenin signaling axis. Science 2005. 310: 1504-1510.
45. Fujino, H., Xu, W. and Regan, J. W., Prostaglandin E2 induced functional expression of early growth response factor-1 by EP4, but not EP2, prostanoid receptors via the phosphatidylinositol 3-kinase and extracellular signal-regulated kinases. J. Biol. Chem. 2003. 278: 12151-12156.
46. Kaisho, T. and Akira, S., Toll-like receptor function and signaling. J. Allergy Clin. Immunol. 2006. 117: 979-987; quiz 988.
47. Akira, S. and Takeda, K., Toll-like receptor signalling. Nat. Rev. Immunol. 2004. 4: 499-511.
48. Lee, S. K., Seo, S. H., Kim, B. S., Kim, C. D., Lee, J. H., Kang, J. S., Maeng, P. J. and Lim, J. S., IFN-gamma regulates the expression of B7-H1 in dermal fibroblast cells. J. Dermatol. Sci. 2005. 40: 95-103.
49. Liu, J., Hamrouni, A., Wolowiec, D., Coiteux, V., Kuliczkowski, K., Hetuin, D., Saudemont, A. and Quesnel, B., Plasma cells from multiple myeloma patients express B7-H1 (PD-L1) and increase expression after stimulation with IFN-{ gamma} and TLR ligands via a MyD88-, TRAF6-, and MEK-dependent pathway. Blood 2007. 110: 296-304.
50. Qian, Y., Deng, J., Geng, L., Xie, H., Jiang, G., Zhou, L., Wang, Y. et al., TLR4 Signaling Induces B7-H1 Expression Through MAPK Pathways in Bladder Cancer Cells. Cancer Invest. 2008: 1.
51. Parsa, A. T., Waldron, J. S., Panner, A., Crane, C. A., Parney, I. F., Barry, J. J., Cachola, K. E. et al., Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma. Nat. Med. 2007. 13: 84-88.
52. Liang, S. C., Latchman, Y. E., Buhlmann, J. E., Tomczak, M. F., Horwitz, B. H., Freeman, G. J. and Sharpe, A. H., Regulation of PD-1, PD-L1, and PD-L2 expression during normal and autoimmune responses. Eur. J. Immunol. 2003. 33: 2706-2716.
53. Tamura, H., Ogata, K., Dong, H. and Chen, L., Immunology of B7-H1 and its roles in human diseases. Int. J. Hematol. 2003. 78: 321-328.
54. Brown, J. A., Dorfman, D. M., Ma, F. R., Sullivan, E. L., Munoz, O., Wood, C. R., Greenfield, E. A. and Freeman, G. J., Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production. J. Immunol. 2003. 170: 1257-1266.
55. Jeong, H.-Y., Lee, Y.-J., Seo, S.-K., Lee, S.-W., Park, S.-J., Lee, J.-N., Sohn, H.-S. et al., Blocking of monocyte-associated B7-H1 (CD274) enhances HCV-specific T cell immunity in chronic hepatitis C infection. J. Leukoc. Biol. 2008. 83: 755-764.
56. Mazanet, M. M. and Hughes, C. C. W., B7-H1 Is Expressed by Human Endothelial Cells and Suppresses T Cell Cytokine Synthesis. J. Immunol. 2002. 169: 3581-3588.
57. Fife, B. T. and Bluestone, J. A., Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways. Immunol. Rev. 2008. 224: 166-182.
58. Selenko-Gebauer, N., Majdic, O., Szekeres, A., Hofler, G., Guthann, E., Korthauer, U., Zlabinger, G. et al., B7-H1 (programmed death-1 ligand) on dendritic cells is involved in the induction and maintenance of T cell anergy. J. Immunol. 2003. 170: 3637-3644.
59. Wang, X., Zhang, Z., Zhang, S., Fu, J., Yao, J., Jiao, Y., Wu, H. and Wang, F. S., B7-H1 up-regulation impairsmyeloid DC and correlates with disease progression in chronic HIV-1 infection. Eur. J. Immunol. 2008. 38: 3226-3236.
60. Freeman, G. J., Long, A. J., Iwai, Y., Bourque, K., Chernova, T., Nishimura, H., Fitz, L. J. et al., Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J. Exp. Med. 2000. 192: 1027-1034.
61. Romani, N., Gruner, S., Brang, D., Kampgen, E., Lenz, A., Trockenbacher, B., Konwalinka, G. et al., Proliferating dendritic cell progenitors in human blood. J. Exp. Med. 1994. 180: 83-93.